This post was originally published on this site
The FDA authorized the vaccine last week, but the manufactured doses were still awaiting quality testing before they could be released.
Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Tuesday voted unanimously to recommend use of the vaccine, and rollout of the shots can begin once the agency’s director signs off on that recommendation.
